APA (7th ed.) Citation

L, B., F, B., D, P., JT, D., VH, J., R, H., . . . U, F. (2024). Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3: :PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia. Haematologica, 109(7), 2290. https://doi.org/10.3324/haematol.2023.283928

Chicago Style (17th ed.) Citation

L, Blumel, et al. "Proteogenomic Profiling Uncovers Differential Therapeutic Vulnerabilities Between TCF3: :PBX1 and TCF3::HLF Translocated B-cell Acute Lymphoblastic Leukemia." Haematologica 109, no. 7 (2024): 2290. https://doi.org/10.3324/haematol.2023.283928.

MLA (9th ed.) Citation

L, Blumel, et al. "Proteogenomic Profiling Uncovers Differential Therapeutic Vulnerabilities Between TCF3: :PBX1 and TCF3::HLF Translocated B-cell Acute Lymphoblastic Leukemia." Haematologica, vol. 109, no. 7, 2024, p. 2290, https://doi.org/10.3324/haematol.2023.283928.